This is a strategic and non-exclusive agreement which opens the door into some of the world’s fastest growing cannabis markets.
Investors will vote on a security consolidation and rebrand as Opyl at an upcoming meeting.
More than 840 bottles were dispensed in October and a final patient was recruited to a study at...
The company’s assets include medical cannabis pharmaceutical solutions to help people manage pain.
The biotech gained up to 5% by lunch on confirming FY20 milestones, including an early-2020...
The Australian and Canadian group is focused on medicinal cannabis supply and development and...
Admedus Ltd's (ASX:AHZ) CEO Wayne Paterson caught up with Proactive's Andrew Scott while in London. The firm recently made what's been described as a transformational move to sell off its CardioCel® and VascuCel® patch business. Paterson says the focus is now firmly on the Adapt...
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.